Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No evidence for direct physical interaction of 5-HT <sub>2A</sub> -mGluR2 receptors <i>in vitro</i> or <i>in vivo</i>.

bioRxiv : the preprint server for biology·2026
Same author

Endogenously generated Dutch-type Aβ non-fibrillar aggregates dysregulate presynaptic neurotransmission in the absence of detectable inflammation.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Neuropathological and Behavioral Effects of Mild Traumatic Brain Injury at High Altitude.

Journal of neurotrauma·2026
Same author

Brain-wide Activity Mapping Reveals the Somatosensory Cortex as a Sex-Specific Regulator of High-Fat Diet Intake.

bioRxiv : the preprint server for biology·2026
Same author

Repeated Stress Escalates Aggression and Activity in Fronto-Limbic Regions in Cntnap2<sup>-</sup>/<sup>-</sup> Mice.

Genes, brain, and behavior·2026
Same author

High-risk outing behaviors and COVID-19-related outcomes: A nationwide longitudinal study in Japan.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2026

Related Experiment Video

Updated: May 19, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Amyloid precursor protein (APP) regulates synaptic structure and function.

Sheue-Houy Tyan1, Ann Yu-Jung Shih, Jessica J Walsh

  • 1Department of Neurosciences, University of California San Diego, La Jolla, CA 92093, USA. s1tyan@ucsd.edu

Molecular and Cellular Neurosciences
|August 14, 2012
PubMed
Summary
This summary is machine-generated.

Amyloid precursor protein (APP) loss impairs synaptic structure and function, particularly in older mice. Soluble APP (sAPP) may be crucial for maintaining hippocampal dendritic integrity, independent of amyloid-beta toxicity.

More Related Videos

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Related Experiment Videos

Last Updated: May 19, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain
10:08

Purification and Aggregation of the Amyloid Precursor Protein Intracellular Domain

Published on: August 28, 2012

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus
08:16

Stereotaxic Infusion of Oligomeric Amyloid-beta into the Mouse Hippocampus

Published on: June 17, 2015

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Neurodegenerative Diseases

Background:

  • Amyloid precursor protein (APP) is central to Alzheimer's disease (AD) pathogenesis, producing amyloid-beta (Aβ) peptides.
  • Synaptic deficits and dendritic spine loss occur early in AD models, preceding amyloid plaque deposition.
  • The specific role of APP itself, independent of Aβ, in synaptic regulation remains unclear.

Purpose of the Study:

  • To investigate the role of APP in regulating synaptic structure and function.
  • To examine the consequences of APP deficiency using an APP knock-out (APP-/-) mouse model.

Main Methods:

  • Primary hippocampal neuron cultures from APP-/- mice and littermate controls.
  • In vivo analysis of CA1 hippocampal neurons in APP-/- mice.
  • Assessment of dendritic spine density, dendritic morphology, and long-term potentiation (LTP).

Main Results:

  • APP-/- neurons showed significantly reduced dendritic spine density (~35% in vitro, ~15% in vivo), partially restored by sAPPα.
  • APP deficiency led to diminished apical dendritic length and arborization in hippocampal neurons.
  • Neuronal morphology deficits were associated with reduced long-term potentiation, evident only in aged (12-15 months) APP-/- mice.

Conclusions:

  • APP, specifically its soluble form (sAPP), is essential for maintaining hippocampal dendritic integrity in an age-dependent manner.
  • These APP-dependent, age-related synaptic changes may contribute to Alzheimer's disease pathology independently of Aβ toxicity.
  • Findings highlight a novel, non-amyloidogenic role for APP in synaptic maintenance relevant to aging and AD.